ANIX
Anixa Biosciences·NASDAQ
--
--(--)
--
--(--)
2.67 / 10
Underperform
Technical rating is Underperform with a 2.67 score. MACD death cross, long lower and upper shadows dominate, all indicating bearish momentum. No bullish signals appear, highlighting significant downside risk.
Analysis Checks(0/3)
Long Lower Shadow
Score1/10
Win Rate32.43%
Hist. Signals37
Avg Return-3.39%
Score1/10
Win Rate32.43%
Hist. Signals37
Avg Return-3.39%
MACD Death Cross
Score3.95/10
Win Rate45.45%
Hist. Signals11
Avg Return2.77%
Score3.95/10
Win Rate45.45%
Hist. Signals11
Avg Return2.77%
Long Upper Shadow
Score3.06/10
Win Rate46.15%
Hist. Signals39
Avg Return1.27%
Score3.06/10
Win Rate46.15%
Hist. Signals39
Avg Return1.27%
Long Lower Shadow
Score1/10
Win Rate32.43%
Hist. Signals37
Avg Return-3.39%
Score1/10
Win Rate32.43%
Hist. Signals37
Avg Return-3.39%
Long Upper Shadow
Score3.06/10
Win Rate46.15%
Hist. Signals39
Avg Return1.27%
Score3.06/10
Win Rate46.15%
Hist. Signals39
Avg Return1.27%
MACD Death Cross
Score3.95/10
Win Rate45.45%
Hist. Signals11
Avg Return2.77%
Score3.95/10
Win Rate45.45%
Hist. Signals11
Avg Return2.77%
Technical Analysis of ANIX?
- ANIX presents a Underperform setup with a Technical Score of 2.67/10. Key technical indicators highlight an RSI of 31.52 and a MACD of -0.05, with the trend anchored by the 50-Day SMA at 2.96. Traders should monitor key support at 2.47 and resistance at 2.79.
